U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT07543965) titled 'Cohort of Repeat Donor Experiences (CORE) Study' on March 25.
Brief Summary: The Plasma Protein Therapeutics Association (PPTA) sponsors the Cohort of Repeat Donor Experiences (CORE) Study. This is a prospective, observational cohort study that will follow Source Plasma donors for up to 2 years during the main study (anticipated to begin in summer 2026) and up to 3 months during the pilot launching in mid-March 2026. This study aims to confirm a lack of negative health effects Source Plasma donors may experience as a result of frequent plasmapheresis. The study will use data obtained through self-report surveys for the duration of ...